Larvol Delta - vTv-Therapeutics-Announces-Initiation-of-Multiple-Ascending-Dose-Study-of-HPP737-an-Oral-PDE4-Inhibitor-for-the-Treatment-of-Psoriasis

HPP737 - vTv Therapeutics

https://www.globenewswire.com/news-release/2021/02/17/2177494/0/en/vTv-Therapeutics-Announces-Initiation-of-Multiple-Ascending-Dose-Study-of-HPP737-an-Oral-PDE4-Inhibitor-for-the-Treatment-of-Psoriasis.html

Feb 17, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next